Patent · US Expired

Reversing the formation of advanced glycosylation endproducts

US6007865A · kind A · utility

23Cited by
7References
45Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 19, 1997
Grant dateDec 28, 1999
Priority date
Expiry dateNov 19, 2017

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2500/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compositions and methods for inhibiting and reversing nonenzymatic cross-linking (protein aging). Accordingly, compositions are disclosed which comprise an agent capable of inhibiting the formation of advanced glycosylation endproducts of target proteins, and which additionally reverse pre-formed crosslinks in the advanced glycosylation endproducts by cleaving alpha-dicarbonyl-based protein crosslinks present in the advanced glycosylation endproducts. Certain agents useful are thiazolium salts. The method comprises contacting the target protein with the composition. Both industrial and therapeutic applications for the invention are envisioned, as food spoilage and animal protein aging can be treated. A novel immunoassay for detection of the reversal of the nonenzymatic crosslinking is also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.